Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
Posted 11 December 2014 | By Alexander Gaffney, RAC,
The US Food and Drug Administration (FDA) is proposing several changes to its adverse event reporting forms, known within the industry as Forms 3500, 3500A and 3500B.
FDA has three adverse event reporting forms it uses to collect information about medical products, including drugs (prescription and non-prescription), biologics, medical devices and dietary supplements.
The most recent of those forms, 3500B, was only launched by FDA in June 2013 as a way to get patients more involved in the regulatory process. However, FDA only permits this form to be submitted by mail or fax, presumably to cut down on malicious or frivolous reporting.
To learn more about FDA's consumer-friendly adverse event reporting form 3500B, please see our June 2013 article, "New Medwatch Form Geared Toward Simple Adverse Event Reporting for Consumers."
Now in a new Federal Register announcement, FDA says it wants to make some changes to all three versions of its Form 3500 in the hopes of bringing the forms "into conformation … with current regulations, rules and guidances."
The changes are mostly intended to add clarity to the forms. For example, FDA proposes changing all three forms to include checkboxes for years, months, weeks and days—a helpful addition if a patient was an infant. Another proposed addition would allow patients to input their weight in either pounds or kilograms—helpful for patients who may not be familiar with the US system of weights and measurements. The date field would also be changed to a format of DD-MM-YYYY to clarify exactly how the date should be formatted.
FDA said these changes would make it easier to scan in forms using optical character recognition software, decreasing the burden on staff.
FDA also said it wants to use a new "race and ethnicity" field to allow for the selection of multiple races—useful information since different races can sometimes be affected by drugs in different ways.
FDA's form will also now apply to compounded pharmaceutical products as well, and will contain a prompt to include data about the "manufacturer/compounder" and the lot number, if applicable.
Federal Register Announcement
Tags: MedWatch, Form 3500, Form 3500A, Form 3500B
Regulatory Focus newsletters
All the biggest regulatory news and happenings.